Conventional chemotherapy for myeloma comprises melphalan plus prednisone or a combined regimen such as vincristine, doxorubicin and dexamethasone. The response rate for these approaches is 40–60% and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results